The action of a gene called ATDC is required for the development of pancreatic cancer, a new study finds.
The work builds on the theory that many cancers arise when adult cells—to resupply cells lost to injury and inflammation—switch back into more “primitive,” high-growth cell types, like those that drive fetal development.
When this reversion happens in the presence of other genetic mistakes, a repair process meant to start and stop quickly continues unchecked.
New details of this cancer-causing switch to primitive cells, and of the role of ATDC in pancreatic cancer formation, are revealed in a study of mice and human patient samples published online May 2 in the journal Genes & Development.
Led by researchers from NYU School of Medicine and the University of Michigan—Ann Arbor, the study found that ATDC must be active if pancreatic cells, when injured, are to reacquire primitive stem-cell qualities and undergo the early steps that lead to the development of pancreatic cancer.
“We found that deleting the ATDC gene in pancreatic cells resulted in one of the most profound blocks of tumor formation ever observed in a well-known mice model engineered to develop pancreatic ductal adenocarcinoma, or PDA, which faithfully mimics the human disease,” says corresponding author Diane Simeone, MD, director of the Pancreatic Cancer Center of NYU Langone Health’s Perlmutter Cancer Center. “We thought the deletion would slow cancer growth, not completely prevent it.”
The search for better treatment in these cases is especially urgent, says Dr. Simeone, given that PDA has the worst prognosis of any major malignancy and is on track to become the second leading cause of cancer-related death by 2030.
Healing Gone Awry
The study focused on acinar cells in the pancreas that secrete digestive enzymes through a network of partnering ducts into the small intestine. These same digestive enzymes can subject this tissue to low levels of damage. In response, acinar cells have evolved to readily switch back into stem cell types that resemble their high-growth ancestors, a feature that they share with pancreatic duct cells.
This ability to regenerate comes at a price, researchers say, because such cells are prone to become cancerous when they also acquire random DNA changes, including those in the gene KRAS that are known to drive aggressive growth in more than 90 percent of pancreatic cancers.
Specifically, stressed acinar cells are known to temporarily undergo acinar-to-ductal metaplasia, or ADM, a step toward a primitive cell type, to resupply cells. This sets the stage for a second shift into pancreatic intraepithelial neoplasia, or PanIN, in which cells no longer multiply under normal controls.
In the current study, the researchers found that mutant KRAS and other genetic abnormalities induced aggressive pancreatic cancer in 100 percent of study mice when the ATDC gene was present and active, but in none of the same cancer-prone mice lacking the gene. Neither did acinar cells in the ATDC “knock-out” mice undergo ADM or transformation to PanIN.
To get a better look at the early steps in pancreatic cancer formation, the research team artificially caused pancreatitis in mice by treating them with cerulein, a signaling protein fragment that damages pancreatic tissue. ATDC gene expression did not increase right after the damage, but did so a few days later and in line with the timeframe required for acinar cells to reprogram genetically into their ductal cell forebears.
Further experiments confirmed that the expression of ATDC triggers beta-catenin, a cell-signaling protein that, upon receiving the right trigger, activates genes including SOX9. Earlier studies linked SOX9 to the development of ductal stem cells and to the aggressive growth seen in PDA. Consistent with this work, the current study found that the inability of cells lacking ATDCto become cancerous was due to their inability to induce SOX9 expression.
The authors also examined ATDC expression in ADM lesions from 12 samples of human pancreatic tissue. The team found it to be more active in human ADM lesions along with beta-catenin and SOX9, and its activation increased further during the transition of ADM into human pancreatic ductal adenocarcinoma.
The findings, says Dr. Simeone, identify ATDC, beta-catenin, SOX9, and their signaling partners as potential targets in the design of new treatment approaches and prevention strategies for pancreatic cancer.
The Latest on: Pancreatic cancer
[google_news title=”” keyword=”pancreatic cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pancreatic cancer
- First pancreatic cancer patient dosed in Radiopharm studyon February 28, 2024 at 11:03 pm
Radiopharm Theranostics says it has dosed its first pancreatic cancer patient in the initial phase of a study aimed at providing doctors with an enhanced screening process for the lethal and ...
- SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Canceron February 28, 2024 at 3:59 pm
SEOUL, South Korea, Feb. 29, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on Feb 27 that the US FDA had granted an orphan drug designation for pancreatic cancer for ...
- Scientists discover mucus allows young pancreatic cancer cells to grow but may also prevent a deadly transformationon February 28, 2024 at 1:48 pm
Knowing exactly what's inside a tumor can maximize our ability to fight cancer. But that knowledge doesn't come easy. Tumors are clusters of constantly changing cancer cells. Some become common cancer ...
- What you need to know about pancreatic canceron February 28, 2024 at 12:03 pm
Pancreatic cancer is called a “silent killer” because it is usually not found until it has spread from the pancreas, making it extremely difficult to treat. Pancreatic cancer, like other cancers, ...
- Researchers looking for patients to participate in pancreatic cancer vaccine trialon February 28, 2024 at 11:02 am
This trial is testing a vaccine to treat pancreatic cancer. Researchers said it could have a huge impact in pancreatic cancer which is often not discovered until later stages. The study is designed ...
- What is pancreatic cancer? All you need to know about its warning signson February 28, 2024 at 3:19 am
Pancreatic cancer is a serious illness that affects the pancreas, an essential organ in the body's digestive system. Despite being relatively rare, it's one of the deadliest forms of cancer, largely ...
- Pankaj Udhas suffered from pancreatic cancer, all about the diseaseon February 27, 2024 at 12:34 am
Legendary ghazal singer Pankaj Udhas passed away on Monday reportedly due to pancreatic cancer. Symptoms to treatment, all you want to know about the cancer.
- Ask the doctors: Researchers use AI to detect pancreatic cancer sooneron February 26, 2024 at 4:00 pm
Dear Doctors: A dear friend was diagnosed with pancreatic cancer. It was so advanced, he died just a month later. I recently saw a discussion on television about using AI to detect it early, while it ...
- Increase in women being diagnosed with pancreatic canceron February 26, 2024 at 7:53 am
New statistics reveal an increase in cases of pancreatic cancer being diagnosed in women. The figures, released by Cancer Research UK (CRUK), came from comparing incidences of pancreatic cancer in the ...
- Ask the doctors: Can AI detect pancreatic cancer earlier?on February 22, 2024 at 9:59 pm
Q: A dear friend was diagnosed with pancreatic cancer. It was so advanced, he died just a month later. I recently saw a discussion on television about using AI to detect pancreatic cancer early, while ...
via Bing News